PSMA PET/MR to guide second prostate biopsy
Part of Cancer, Kidney & urinary clinical trials.
This study uses a special imaging scan (PSMA PET/MR) to help doctors see if a second prostate biopsy is needed. It aims to make the biopsy more accurate, so you may get a clearer diagnosis and avoid unnecessary procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 40 or older.
- Your PSA level is between 4 and 20 ng/mL (a blood test for prostate health).
- You have not had prostate surgery or radiation treatment before.
- You do not have acute prostatitis (sudden prostate swelling or infection).
- You do not have bleeding problems, active infections, or severe hemorrhoids or other issues in the rectal area.
- You are not allergic to local anesthetics and can tolerate a biopsy procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a special PET scan (PSMA PET/CT) to guide prostate biopsy can help find cancer more accurately and in real time. It might help men who need a biopsy because of high PSA levels or abnormal MRI results.
This study tests whether a special PET scan (PSMA PET) can better detect prostate cancer in men whose MRI results are unclear. If it works, it may help avoid unnecessary biopsies or find cancer sooner.
This study tests whether a special scan (PSMA PET/MRI) combined with a standard MRI can better detect prostate cancer. It is for men who have not had a biopsy yet and are suspected of having prostate cancer.
This trial compares two imaging techniques—PSMA PET/CT and MRI—to see which one better finds and outlines prostate cancer tumors. You'll receive both scans to help doctors understand which method works best for newly diagnosed prostate cancer.
This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.
This trial tests if combining a PSMA PET scan with an MRI can better detect clinically significant prostate cancer than MRI alone. It may help men who have not had a prostate biopsy before and have certain risk factors.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.